Company intelligence / Profile preview

Moon Surgical

Paris, Île-de-France, Francemoonsurgical.com ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Moon Surgical’s Maestro System has received FDA clearance for its commercial version and CE mark in Europe. The system has been used in over 1,100 patients across the US and Europe as of March 2025. Clinical use spans general, bariatric, gynecologic and urologic surgeries. The company’s ScoPilot AI feature was the first FDA-cleared AI-driven intraoperative movement control on a robotic platform. Early clinical experience demonstrates enhanced surgeon autonomy and workflow efficiency.

Therapeutic areas: OtherMen's HealthMetabolic DisordersWomen's Health
Modalities: DeviceArtificial Intelligence-enabled device
Industry: Surgical Medical Devices

Partnerships

NVIDIA (for Holoscan AI integration)Sofinnova Partners/MD Start III Fund as lead investor and accelerator partner

Beyond the preview

Go deeper on Moon Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Moon Surgical.

Explore the full profile